A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Dabigatran D4 | CAS 1618637-32-3 - Request Quote

Picture of Dabigatran D4

Dabigatran D4

SZ CAT No:SZ-D012D02
CAS No
1618637-32-3
Mol.F.
C25H21D4N7O3
Mol.Wt.
475.6
Inv. Status
Synthesis on demand
Rel. CAS No2070015-06-2 (HCl salt)

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Dabigatran D4 is chemically 3-(2-(((4-Carbamimidoylphenyl-2,3,5,6-d4)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoic acid. Dabigatran D4 is supplied with detailed characterization data compliant with regulatory guideline. Dabigatran D4 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Dabigatran.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 1618637-32-3

Purchase 1618637-32-3

Order 1618637-32-3

Enquire 1618637-32-3

price of 1618637-32-3

1618637-32-3 Supplier

1618637-32-3 Manufacturer

1618637-32-3 Exporter

buy high quality Dabigatran D4

Purchase Dabigatran D4

Dabigatran D4 suppliers

Dabigatran D4 manufacturers

Dabigatran D4 price

Order Dabigatran D4

Enquire Dabigatran D4

Dabigatran D4 cost

Dabigatran D4 Supplier

Dabigatran D4 Distributor

Dabigatran D4 for Method Validation

Dabigatran Reference Standard

Dabigatran D4 for ANDA Filing

Dabigatran D4 for Forced Degradation Studies

Dabigatran D4 Identification Standards

Dabigatran D4 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,